ArchPoint Investors - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 87 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ArchPoint Investors ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$4,580,581
-18.3%
1,449,5510.0%1.75%
-19.4%
Q2 2023$5,609,762
+39.7%
1,449,5510.0%2.17%
+24.2%
Q1 2023$4,015,256
+53.9%
1,449,5510.0%1.75%
+41.5%
Q4 2022$2,609,192
-15.1%
1,449,5510.0%1.24%
-1.6%
Q3 2022$3,073,000
-21.2%
1,449,5510.0%1.26%
-18.8%
Q2 2022$3,899,000
-38.0%
1,449,5510.0%1.54%
-28.8%
Q1 2022$6,291,000
-16.2%
1,449,5510.0%2.17%
-2.6%
Q4 2021$7,509,0001,449,5512.23%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders